DS Admin
Administrative AccessNavigation
ALLSCRIPTS (MDRX) 2015 Event
Loading the player...
1 2015 - Document Top 30 Entities
1. United States
2. California
3. National Cancer Institute
4. National Institute of Health the National Cancer Center
5. U.S.
6. Ambuhl Torie
7. C.T. CA Memorial Sloan Kettering
8. Paul black
9. Rick Bolton
10. Rick Pullman
2. California
3. National Cancer Institute
4. National Institute of Health the National Cancer Center
5. U.S.
6. Ambuhl Torie
7. C.T. CA Memorial Sloan Kettering
8. Paul black
9. Rick Bolton
10. Rick Pullman
11. Torrie
12. U.K.
13. Cashel
14. E.H.R.
15. Electronic Medical Records
16. EMS
17. J.P. Morgan
18. Jemma
19. Mike
20. MIT
12. U.K.
13. Cashel
14. E.H.R.
15. Electronic Medical Records
16. EMS
17. J.P. Morgan
18. Jemma
19. Mike
20. MIT
Amplitude by Second
Monetary Figure Discussions
Top 5 Locations by Importance
Most Financially Relevant Locations
Psychographics
Top 5 Conceptual Data Categories
Good
morning
everybody
.
My
name
is
Mike
new
show
on
the
health
care
I.T.
analyst
here
at
J.P.
Morgan
and
it's
my
pleasure
to
introduce
our
next
presenting
company
all
scripts
with
us
today
presented
for
the
company
it
is
C.E.O.
Paul
black
and
C.F.O.
and
President
Rick
Pullman
.
They'll
be
available
for
Q.
and
A
in
the
Olympic
room
following
the
presentation
and
with
that
I'll
hand
it
over
to
Paul
thank
you
very
much
thank
you
.
Greetings
everybody
.
Paul
black
C.E.O.
of
all
scripts
would
like
to
take
you
a
little
bit
through
the
story
this
morning
.
Appreciate
everybody
coming
and
taking
the
time
to
spend
it
with
us
today
from
a
from
a
corporate
corporate
overview
.
We're
filing
a
case
this
morning
on
the
some
of
the
announcers
would
that
we
made
and
some
of
the
information
that's
in
the
packet
in
our
company
so
all
scripts
.
Rick
and
I've
been
here
for
a
little
over
three
years
there's
been
a
lot
of
work
that's
gone
on
to
really
position
the
company
for
success
and
we
have
a
lot
of
updates
to
bring
you
today
and
you
think
about
what
we
do
as
a
company
.
There's
really
four
main
things
that
we
do
four
main
things
we
supply
to
the
marketplace
on
a
global
basis
.
First
of
all
we
have
electronic
medical
records
systems
we
have
record
systems
for
inpatient
outpatient
amatory
electronic
integrated
delivery
networks
we
have
four
large
multi-group
specialty
practices
and
we
also
have
.
Electronic
Medical
Records
for
a
small
community
physician
practices
have
a
platform
for
Population
Health
which
we've
leaned
into
the
two
thousand
and
thirteen
timeframe
a
lot
of
work
has
gone
on
in
that
regard
from
a
connectivity
standpoint
but
also
from
a
cost
basis
so
we
are
one
of
the
few
people
that
actually
provide
the
cost
accounting
system
when
you
think
about
quality
care
these
days
people
talk
about
all
comes
in
quality
divided
by
cost
.
So
having
a
costing
system
if
you're
in
being
the
value
of
a
scarcity
environment
are
very
important
.
Third
platform
that
we
have
as
a
consumer
platform
and
I
distinguish
consumer
from
patient
engagement
.
We'll
talk
about
that
throughout
the
course
of
the
platform
throughout
the
course
of
the
day
today
and
in
the
last
platform
that
we
are
talking
about
in
one
or
investing
in
is
a
precision
medicine
platform
.
If
the
the
organization
that
we
have
is
manifest
by
a
lot
of
people
that
work
very
hard
each
and
every
day
over
seven
thousand
associates
we
also
have
a
very
large
vast
installed
base
on
a
global
basis
that
it's
all
based
it
has
forty
five
thousand
physician
office
practices
in
the
United
States
and
when
you
think
about
what
it
means
to
be
an
Accountable
Care
Organization
one
of
the
main
components
to
being
and
having
an
effective
accountable
care
is
having
primary
care
physicians
being
able
to
assess
patients
and
be
able
to
manage
them
through
a
continuum
of
care
.
We
also
have
over
four
hundred
thousand
connections
that
people
that
are
connected
to
caregivers
connected
to
consumers
will
talk
about
five
point
seven
million
people
in
our
portal
today
that
are
in
a
single
instance
in
the
cloud
that
are
actively
interfacing
with
their
record
on
a
day
to
day
basis
.
We
also
have
over
two
hundred
two
thousand
five
hundred
hospitals
A
hundred
eighty
thousand
physicians
seventeen
thousand
post
acute
facilities
and
we
manage
over
twelve
million
referrals
each
and
every
year
.
So
the
installed
base
is
a
acute
care
in
the
ample
Torrie
opposed
to
Q.
and
A
consumer
oriented
suite
of
solutions
that
are
out
there
in
production
today
not
from
a
from
from
a
directional
standpoint
but
from
an
operational
day
to
day
management
of
.
And
that's
what
we
do
from
an
industry
standpoint
this
is
a
very
complex
industry
most
of
you
have
been
in
this
room
have
been
students
of
this
for
a
very
long
period
of
time
.
But
it
is
two
thousand
and
sixteen
and
we
all
just
got
a
year
older
and
we
will
hopefully
I'll
get
a
year
older
this
year
.
The
aging
population
is
it
is
a
dynamic
that's
been
going
on
throughout
the
course
of
history
and
in
this
case
from
an
economics
and
macro
economics
and
what's
going
on
specifically
United
States
and
other
parts
of
the
world
a
very
important
component
when
you
think
about
governments
you
think
about
other
agencies
employers
payers
who
are
accountable
for
the
financial
side
of
the
equation
with
regard
to
health
.
Over
five
trillion
dollars
have
been
projected
to
be
spent
in
the
United
States
on
health
care
alone
up
from
the
three
billion
or
three
trillion
today
clearly
unsustainable
number
in
a
number
that
continues
to
grow
as
we
expect
folks
to
.
Hit
that
can
consume
health
care
over
the
course
of
the
next
fifteen
to
ten
to
fifteen
years
and
we
are
also
in
an
environment
in
the
United
States
and
also
around
the
world
where
you
can
be
guaranteed
one
thing
and
that
is
you
can
get
paid
less
for
next
year
and
this
year
for
doing
more
work
and
so
it's
an
extraordinarily
complex
environment
that
people
that
are
running
health
care
systems
have
to
navigate
through
each
and
every
day
.
The
switch
on
top
of
that
reimbursement
challenge
and
cost
challenge
is
a
it
is
a
reimbursement
component
with
regard
to
where
the
market's
gone
and
going
from
a
volume
based
organization
and
a
reimbursement
model
to
being
a
value
.
So
you
get
paid
for
quality
you
get
paid
for
outcomes
as
compared
to
getting
paid
for
seeing
as
many
patients
each
and
every
day
.
In
certain
regions
of
the
country
that
uptake
has
not
been
as
as
advanced
in
other
regions
of
the
country
like
where
we
sit
in
California
today
they're
doing
full
cavitation
for
over
thirty
years
.
Those
represent
big
challenges
for
our
clients
and
the
movement
from
A
to
B.
from
volume
to
value
has
been
a
big
topic
it's
been
talked
about
for
a
long
time
which
drives
a
lot
of
the
the
market
requirements
that
we're
seen
in
in
the
environment
that
we
operate
in
today
.
If
you
look
at
that
what
that
means
from
a
strategic
imperative
for
our
clients
if
you
look
at
what
the
what
they're
faced
with
each
and
every
day
that
five
percent
of
the
population
actually
consumes
over
far
forty
five
percent
of
the
cost
and
end
of
the
care
that's
an
incredibly
important
statistic
when
you
think
about
if
you're
managing
that
if
you're
at
risk
clinically
and
financially
for
that
population
how
are
you
going
to
manage
and
how
you
identify
those
people
how
you
manage
them
through
a
care
protocol
and
how
do
you
take
care
of
them
to
manage
those
costs
and
get
a
better
outcome
for
them
for
a
long
extended
extended
period
of
time
.
The
the
the
piece
on
that
last
chart
that
is
important
is
not
only
do
you
have
a
very
large
dollar
being
consumed
by
a
very
small
number
of
people
but
you
also
have
a
component
of
that
very
complex
set
of
diagnostics
in
very
complex
set
of
conditions
that
a
poll
a
chronic
patient
has
.
So
it's
not
one
pill
it's
not
one
protocol
it's
a
multi
variant
and
that's
another
reason
why
we
think
in
we
are
confident
that
our
emphasis
on
precision
medicine
to
help
can
not
only
control
that
top
five
percent
of
the
consumption
but
that's
going
to
be
a
very
important
way
that
we
manage
and
help
our
clients
manage
through
that
.
Our
value
proposition
is
it's
pretty
simple
and
that
we
believe
that
we
have
to
combine
all
patient
data
not
just
patient
data
.
I
don't
want
to
electronic
medical
records
but
patient
data
from
the
entire
community
in
order
for
it
.
People
to
make
better
decisions
we
can
plan
it
in
one
single
place
and
we
poll
put
it
in
an
organization
what
we
call
the
single
source
of
truth
we
do
that
through
our
connectivity
platform
.
D.B.
Motion
we
then
provide
insights
to
people
that
are
in
the
care
management
area
of
the
organizations
in
order
to
be
able
to
determine
bifurcate
that
prior
chart
what
people
have
what
conditions
and
what
care
protocols
should
they
be
on
what
care
protocols
are
they
on
and
then
tracking
the
results
of
the
care
protocol
that
they
are
on
.
Coordinate
that
care
across
the
community
not
just
across
an
inpatient
setting
not
just
cross
and
post
acute
setting
but
across
the
entire
community
and
providing
tools
and
solutions
that
allow
people
to
actually
core
need
to
care
.
We
also
engage
patients
in
managing
their
care
in
their
health
by
giving
them
access
not
only
to
the
electronic
medical
record
that
we
have
but
our
patient
portal
allows
access
to
all
ear
Mars
.
We
are
not
only
wired
to
our
own
it's
called
a
on
tethered
patient
portal
in
is
one
of
very
few
in
the
marketplace
that
allow
that
to
occur
.
We
also
enable
change
the
point
of
care
so
a
lot
of
people
talk
about
population
health
a
lot
of
people
talk
about
analytics
in
what
we
have
learned
over
a
long
period
of
time
in
working
with
physicians
and
caregivers
.
If
you
don't
incorporate
that
information
if
you
don't
incorporate
that
insight
into
the
bedside
into
the
clinic
into
the
workflow
without
a
lot
of
disruption
to
the
way
people
are
operating
the
way
people
are
thinking
I
have
to
log
in
a
log
out
to
multiple
systems
.
The
workflow
component
of
this
has
been
highly
glossed
over
and
it's
one
of
the
reasons
why
we
think
our
population
L.
solutions
are
the
uptake
that
we
have
in
that
regard
are
surely
effective
at
the
biggest
most
important
thing
I
learned
when
I
first
got
here
when
I
want
to
enlarge
clients
is
that
when
people
are
making
decisions
clinicians
they
don't
want
to
log
in
log
out
they
don't
have
to
click
on
another
tab
they
want
information
to
be
brought
to
them
in
a
delta
view
in
other
words
since
the
last
time
I
saw
the
patient
what
has
changed
is
there's
if
there's
information
that
I
trust
from
other
sources
source
systems
I
want
to
know
about
what
my
other
colleagues
have
told
me
about
this
patient
across
the
community
.
When
I
see
that
information
based
on
my
specialty
type
I
will
make
a
different
decision
and
one
of
our
largest
clients
sixty
percent
of
the
time
that
they
click
on
the
community
view
.
Of
that
patient
they
make
a
different
clinical
decision
which
is
a
phenomenally
large
statistic
when
you
think
about
.
So
why
is
population
health
management
important
you
can't
manage
a
population
unless
you
have
the
entirety
of
their
medical
record
in
front
of
you
as
you're
trying
to
take
care
and
make
decisions
about
their
health
care
.
But
as
we
execute
across
the
platforms
the
breadth
and
depth
of
the
solutions
that
we
have
cover
amatory
acute
post
acute
which
is
extraordinary
large
piece
of
work
health
care
is
going
community
as
well
as
consumer
is
I've
talked
in
the
past
when
we
have
tools
for
many
different
issues
.
These
areas
obviously
the
impatient
patient
not
only
the
electronic
medical
records
but
solutions
that
where
we
do
the
remote
hosting
of
those
solutions
for
our
clients
and
in
many
cases
will
totally
outsource
the
entirety
of
that
of
their
solutions
so
that's
a
big
piece
of
the
revenue
growth
driver
that
Rick
will
talk
about
in
a
minute
.
We're
getting
a
lot
of
we
give
you
we
received
and
we
have
achieved
a
lot
of
momentum
as
a
result
of
not
only
business
travelers
but
a
lot
of
our
clients
have
had
success
.
So
we're
pleased
with
the
success
that
our
clients
have
demonstrated
through
their
achievement
of
his
level
seven
the
National
Institute
of
Health
which
is
a
very
little
known
Jemma
from
our
standpoint
with
wit
with
regard
to
rest
of
the
world's
understanding
of
what
we
do
.
The
National
Institute
of
Health
is
one
the
largest
research
organizations
in
the
world
.
They
have
over
seventy
one
thousand
seven
hundred
different
clinical
trials
going
on
at
any
point
in
time
they
do
bench
to
bedside
back
to
the
bench
that
is
an
all
scrip
sunrise
client
.
The
National
Cancer
Institute
also
is
running
on
that
platform
.
They
were
achieved
EMS
level
seven
certification
which
is
the
highest
level
of
certification
you
can
receive
for
total
automation
.
Got
another
client
receive
the
Davies
award
which
is
an
X.
extraordinarily
prestigious
award
that
on
their
behalf
because
of
their
accomplishments
with
clinically
and
financially
through
the
use
electronic
medical
records
system
they
were
able
to
achieve
that
.
We
have
over
five
hundred
sixty
new
clients
through
the
Q
three
of
last
year
that
we
previously
announced
we
had
over
eight
hundred
different
source
systems
that
are
attached
and
operational
for
D.B.
Motion
for
interoperability
layer
.
So
again
we're
not
talking
about
being
open
we
can
demonstrate
it
.
We
have
entire
countries
that
operate
inpatient
outpatient
Ambuhl
Torie
the
military
as
well
the
payment
system
all
attached
to
the
D.B.
Motion
platform
and
that's
an
extraordinarily
important
component
.
When
we
think
about
an
open
connected
community
of
health
.
A
big
piece
of
the
openness
is
a
demonstration
of
that
.
We
celebrated
on
December
twenty
fourth
of
this
year
.
Bless
you
.
After
three
years
of
counting
our
billionths
transaction
that
has
gone
through
an
A.P.I.
layer
.
So
where
we
EK
open
in
express
our
A.P.I.
is
to
third
party
developers
as
well
as
our
client
clients
.
When
a
client
developed
or
a
third
party
developed
application
it
puts
it
makes
a
call
to
an
electron
or
one
of
our
electronic
medical
records
we
count
that
we
had
a
billionth
transaction
so
when
we
talk
about
and
we
distinguish
our
company
in
the
marketplace
from
others
and
we
talk
about
open
we
can
demonstrate
it
in
multiple
different
ways
.
And
lastly
on
my
point
the
future
of
precision
medicine
the
patient
specificity
around
having
additional
diagnostic
capabilities
that
are
available
in
the
marketplace
today
are
profound
.
The
work
that
you've
seen
us
work
do
with
not
only
the
National
Institute
of
Health
the
National
Cancer
Center
but
also
with
large
organizations
like
C.T.
CA
Memorial
Sloan
Kettering
and
others
where
they
are
doing
and
have
been
working
on
genomic
sequencing
for
a
long
period
of
time
bringing
that
information
back
into
the
workflow
with
the
phenotypic
information
that
resides
in
electronic
medical
record
as
a
result
of
tissue
and
blood
but
blood
sampling
allow
us
to
provide
an
extraordinarily
detailed
level
of
specificity
around
protocol
adherence
as
well
as
protocol
selection
.
And
on
a
going
forward
basis
this
newfound
medical
insight
is
being
developed
each
and
every
day
is
I
think
a
very
important
in
profound
on
set
of
capabilities
that
we
will
have
.
And
as
the
F.D.A.
talks
about
not
only
do
we
want
to
compress
the
amount
of
time
frame
to
get
the
clinical
trials
are
completed
they
also
want
to
get
that
information
in
those
new
protocols
out
into
the
community
much
more
quickly
not
to
be
locked
into
large
academic
medical
centers
to
MIT
but
to
make
that
much
more
compelling
and
make
that
much
more
available
.
And
when
you
think
about
our
capabilities
by
having
forty
five
thousand
physician
office
practices
spread
throughout
the
United
States
spread
throughout
main
streets
right
throughout
the
rural
areas
of
the
country
we're
quite
excited
about
our
capability
to
bring
that
information
to
that
primary
care
caregiver
.
Thank
you
very
much
.
That
will
turn
put
him
over
to
Mr
Rick
Bolton
our
President
and
C.F.O.
.
OK
Good
morning
everyone
thanks
Paul
.
I
just
want
to
pivot
now
the
conversation
talk
a
little
bit
about
our
financial
model
and
what
we
see
as
our
financial
opportunity
ahead
.
We
have
talked
for
some
time
now
to
those
who
have
followed
us
about
four
planks
of
growth
that
we
see
as
the
opportunity
for
their
company
to
pursue
as
we
go
forward
.
And
those
are
as
I
list
on
the
slide
here
so
first
it
starts
with
H.R.
replacements
the
market
for
E.H.R.'s
today
is
largely
a
mature
market
.
We
have
a
very
unnatural
industry
structure
meaning
way
too
many
vendors
out
there
and
what
we're
seeing
is
some
vendors
slowing
down
their
investment
in
their
solutions
and
built
on
old
technology
in
particular
and
that
gives
the
opportunity
to
have
some
consolidation
.
So
there
will
be
a
market
share
winners
market
share
losers
as
we
come
as
we
evolve
to
a
more
natural
industry
structure
.
We
expect
to
be
a
market
share
winner
.
We've
invested
heavily
in
our
solutions
we
amped
up
our
investment
significantly
three
years
ago
.
We
continue
to
invest
at
those
levels
.
They
are
industry
leading
levels
in
terms
of
a
percentage
of
our
revenues
.
And
though
that
investment
gives
us
the
opportunity
to
be
a
share
shift
when
our
second
opportunity
is
initial
adoption
of
new
digital
tools
.
So
population
health
management
is
an
area
that
most
providers
are
focused
on
today
as
they're
forced
to
manage
risk
for
the
first
time
.
And
that
amount
of
risk
they
have
to
manage
is
growing
significantly
as
they
look
ahead
.
They
need
tools
to
be
able
to
accommodate
that
and
that's
really
what
the
population
health
umbrella
stands
for
.
The
third
area
of
opportunity
for
us
is
improving
and
increasing
our
share
of
wallet
with
clients
by
providing
more
recurring
services
to
them
.
So
today
are
today
our
mix
of
business
with
our
clients
is
about
two
thirds
of
our
business
it
comes
from
our
software
about
a
third
of
our
business
comes
from
various
services
that
we
provide
.
We
see
an
opportunity
to
bring
that
ratio
closer
in
line
with
what
we
see
from
some
other
competitors
in
our
in
our
universe
.
So
a
good
opportunity
for
us
to
expand
our
services
.
And
then
finally
bringing
our
solution
stack
outside
the
U.S.
So
we
see
in
general
the
out
there
outside
the
U.S.
is
behind
us
in
terms
of
adoption
of
clinical
tools
and
we
have
some
very
strong
bulkheads
of
strength
out
mostly
in
English
speaking
countries
where
we
have
the
opportunity
to
grow
from
those
points
of
presence
.
We've
had
a
lot
of
momentum
in
these
areas
.
So
this
isn't
just
theory
.
We've
on
the
replacements
we've
seen
twenty
new
sunrise
sunrises
are
acute
in-patient
solution
twenty
ninth's
facilities
added
since
two
thousand
and
thirteen
.
We've
seen
some
nice
steady
revenue
growth
in
population
health
solutions
very
strong
growth
in
recurring
services
solutions
and
then
also
our
increased
presence
outside
the
U.S.
So
both
in
the
third
quarter
as
well
as
the
fourth
quarter
we
announced
significant
new
wins
in
the
U.K.
.
So
the
best
measure
of
momentum
is
probably
really
our
sales
activity
and
in
our
industry
parlance
we
call
that
bookings
.
This
is
a
chart
over
the
last
two
years
of
what
our
quarterly
bookings
performance
has
been
.
There
is
a
little
seasonality
in
the
buying
patterns
so
you
do
see
a
dip
when
you
go
from
Q
four
to
Q
one
.
But
you
can
see
on
the
right
side
of
this
graph
how
we've
had
a
nice
steady
increase
throughout
the
year
.
Each
of
our
first
three
quarters
of
the
year
were
records
for
the
company
and
we
announced
this
morning
that
our
fourth
quarter
is
also
expect
is
a
record
as
well
.
So
as
when
we
draw
this
graph
for
you
next
time
you'll
see
this
trend
line
continue
in
terms
of
revenue
our
revenue
results
have
have
been
if
you
looked
at
us
just
casually
you'd
see
that
for
the
last
couple
of
years
top
line
is
kind
of
stalled
.
There's
really
two
stories
going
on
there
though
there's
recurring
revenue
growth
and
then
there's
also
are
nonrecurring
and
so
our
recurring
revenue
has
grown
pretty
nicely
throughout
the
year
it's
around
six
percent
these
are
nine
month
numbers
.
But
that
was
offset
almost
entirely
with
a
reduction
in
non
recurring
revenue
we've
spoken
in
the
past
about
the
reasons
for
that
but
we
had
a
lot
of